Inventor
PAYNE JOSEPH E
US54 patents
⚠️ This page may combine multiple inventors who share the name “PAYNE JOSEPH E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARCTURUS THERAPEUTICS INC
31 patentsUS9593077B2Mar 14, 2017
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC88 citations99
US9567296B2Feb 14, 2017
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC77 citations99
US9670152B2Jun 6, 2017
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC52 citations98
US10526284B2Jan 7, 2020
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC16 citations94
US10487105B2Nov 26, 2019
Trinucleotide MRNA cap analogs
ARCTURUS THERAPEUTICS INC19 citations94
US9896413B2Feb 20, 2018
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC19 citations94
US9365610B2Jun 14, 2016
Asymmetric ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC30 citations94
US9951002B2Apr 24, 2018
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC12 citations93
US9850202B2Dec 26, 2017
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC15 citations93
US10383952B2Aug 20, 2019
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC13 citations92
US9580711B2Feb 28, 2017
Lipid particles with asymmetric cationic lipids for RNA delivery
ARCTURUS THERAPEUTICS INC20 citations92
USRE49233EOct 4, 2022
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC2 citations84
US10980895B2Apr 20, 2021
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC8 citations84
US10961188B2Mar 30, 2021
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC7 citations84
US10781169B2Sep 22, 2020
Method of synthesis of an ionizable cationic lipid
ARCTURUS THERAPEUTICS INC6 citations84
US10399937B2Sep 3, 2019
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC2 citations84
US10233148B2Mar 19, 2019
Aromatic ionizable cationic lipid
ARCTURUS THERAPEUTICS INC6 citations84
US10227302B2Mar 12, 2019
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC12 citations84
US9856475B2Jan 2, 2018
Formulations for treating amyloidosis
ARCTURUS THERAPEUTICS INC5 citations84
US10815463B2Oct 27, 2020
Messenger UNA molecules and uses thereof
ARCTURUS THERAPEUTICS INC6 citations73
US10556861B2Feb 11, 2020
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC1 citations73
US10421964B2Sep 24, 2019
UNA oligomers and compositions for treating amyloidosis
ARCTURUS THERAPEUTICS INC2 citations73
US9982259B2May 29, 2018
Transthyretin allele selective UNA oligomers for gene silencing
ARCTURUS THERAPEUTICS INC5 citations73
US9834510B2Dec 5, 2017
Aromatic ionizable cationic lipid
ARCTURUS THERAPEUTICS INC4 citations73
USRE50681EDec 2, 2025
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC0 citations63
US12286395B2Apr 29, 2025
Method of synthesis of an ionizable cationic lipid
ARCTURUS THERAPEUTICS INC0 citations63
US12527881B2Jan 20, 2026
Ionizable cationic lipid for RNA delivery
ARCTURUS THERAPEUTICS INC0 citations62
US12220485B2Feb 11, 2025
Method of making lipid-encapsulated RNA nanoparticles
ARCTURUS THERAPEUTICS INC0 citations62
US11737979B2Aug 29, 2023
Method of making lipid-encapsulated RNA nanoparticles
ARCTURUS THERAPEUTICS INC1 citations62
US10604758B2Mar 31, 2020
Therapeutic oligomers for treating amyloidosis
ARCTURUS THERAPEUTICS INC0 citations52
US10519447B2Dec 31, 2019
Therapeutic UNA oligomers and uses thereof
ARCTURUS THERAPEUTICS INC0 citations52
NITTO DENKO CORP
12 patentsUS9242001B2Jan 26, 2016
Cationic lipids for therapeutic agent delivery formulations
NITTO DENKO CORP14 citations92
US10100004B2Oct 16, 2018
Compounds for targeting drug delivery and enhancing siRNA activity
NITTO DENKO CORP4 citations84
US9456984B2Oct 4, 2016
Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier
NITTO DENKO CORP10 citations84
US10196637B2Feb 5, 2019
Retinoid-lipid drug carrier
NITTO DENKO CORP7 citations83
US9963424B2May 8, 2018
Cationic lipids for therapeutic agent delivery formulations
NITTO DENKO CORP8 citations83
US9308267B2Apr 12, 2016
Lipids for therapeutic agent delivery formulations
NITTO DENKO CORP8 citations83
US10195145B2Feb 5, 2019
Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier
NITTO DENKO CORP4 citations73
US10000447B2Jun 19, 2018
Compounds for targeting drug delivery and enhancing siRNA activity
NITTO DENKO CORP2 citations73
US11084779B2Aug 10, 2021
Cationic lipids for therapeutic agent delivery formulations
NITTO DENKO CORP2 citations72
US10441659B2Oct 15, 2019
Lipids for therapeutic agent delivery formulations
NITTO DENKO CORP3 citations72
US11103583B2Aug 31, 2021
Lipids for therapeutic agent delivery formulations
NITTO DENKO CORP0 citations62
US10669229B2Jun 2, 2020
Compounds for targeting drug delivery and enhancing siRNA activity
NITTO DENKO CORP0 citations52
NIITSU YOSHIRO
4 patentsUS8741867B2Jun 3, 2014
Retinoid-liposomes for treating fibrosis
NIITSU YOSHIRO34 citations93
US9393315B2Jul 19, 2016
Compounds for targeting drug delivery and enhancing siRNA activity
NIITSU YOSHIRO12 citations92
US9011903B2Apr 21, 2015
Cationic lipids for therapeutic agent delivery formulations
NIITSU YOSHIRO26 citations92
US8664376B2Mar 4, 2014
Retinoid-liposomes for enhancing modulation of HSP47 expression
NIITSU YOSHIRO30 citations92
COSFORD NICHOLAS D
1 patentMERCK SHARP & DOHME
1 patentC/O ARCTURUS THERAPEUTICS INC
1 patentShowing the top 50 of 54 patents by PatentIndex Score.